Current Bids
Supply Chain Management
Sourcing & Contract Management
Request for Qualification
Bid Number #: Cx Major FY21
RFx Name: Commissioning Services Major Projects FY21 ME
RFx Information:
Open: Jan 21, 2021 3:00 PM
Close: Feb 18, 2021 2:00 PM
Contact Information:
Name: Mary E Mueller
Email: memuelle@mdanderson.org
Phone: 713.745.2102
The University of Texas MD Anderson Cancer Center
Commissioning Services Major Projects FY21 ME - Cx Major FY21
Introduction to MD Anderson
MD Anderson is known throughout the world for high-quality cancer care, research, academic programs and prevention services. Since its establishment in 1941, MD Anderson has made major contributions to improve the outlook for cancer patients everywhere.
MD Anderson was one of the first three federally designated comprehensive cancer centers by the National Cancer Act of 1971. A survey of health professionals has routinely ranked MD Anderson as one of the two premier cancer centers in the nation for the past eight years. Over 55,000 persons annually seek care at MD Anderson. The team approach to cancer care, pioneered at MD Anderson, has been strengthened by consolidating specialty clinics into multi-disciplinary care centers that allow patients to receive more ambulatory care and treatment in a single location.
MD Anderson offers one of the largest bone marrow and stem cell transplantation programs, as well as clinical trials to improve existing therapies. Teams of clinical specialists collaborate with scientists on problems of common interest and test theories that shorten the application of better treatment methods. Translational research studies are responsible for the promising field of chemoprevention, which uses synthetic vitamins to reverse pre-malignant lesions and halt the recurrence of some cancers, and for innovative gene therapy strategies being evaluated for several forms ofcancer.
With faculty and staff working in more than 30 buildings in the greater Houston area and in central Texas, MD Anderson is the largest freestanding cancer center in the world. The physical plant covers more than 11 million square feet, featuring the latest equipment and facilities to support growing needs in outpatient and inpatient care, research, prevention and education. It includes inpatient hospital facilities with 571 beds.
Construction projects include the addition of 12 floors that can accommodate more than 300 new inpatient beds in Alkek Hospital on the North Campus; two new research buildings on the South Campus that will house the Center for Advanced Biomedical Imaging Research and Center for Targeted Therapy as part of the McCombs Institute; and MD Anderson's first facility on its Mid Campus, a 25-story building to support current office space and future growth needs.
In addition to its main campus in the Texas Medical Center and two research campuses in Bastrop County, Texas, MD Anderson has developed a number of local, national and international affiliations
RFx Overview
Request for Qualifications for Commissioning Services of Major Projects. Please refer to RFQ Section 2.2 "Description of Required Services" for details.
Note: A pre-proposal conference is required. Attendance at this meeting is highly recommended for all potential Suppliers. Attendees are limited to two (2) representatives per company.
Pre-Bid Location: | Videoconference via Skype, see RFQ Section 1.12 |
Date / Time: | Tuesday, January 26, 2021 1:00 PM |
Reserve by: | Monday, January 25, 2021 1:00 PM |
Send your Pre-Bid reservation to: | memuelle@mdanderson.org |
Pre-Bid Comments: | PreSubmittal conference will be held via Skype. Please send RSVP via email to memuelle@mdainderson.org by January 25th at 1 PM with name of attendee, firm name and email address. Limit of two attendees per firm. |
Questions related to this RFP must be sent via the information request form. All questions must be received no later than January 28, 2021 4:00 PM. Questions received after this time will not be accepted. Questions will not be answered via telephone. All answers to any questions or inquiries will be posted on the webpage for all Suppliers to access. It is the intent of MD Anderson to respond to all questions and concerns; however, MD Anderson shall reserve the right to decline to respond to any question or concern.
It is important to note that the supplier or suppliers selected to develop MD Anderson's RFP are not automatically qualified to engage with the Institution for purposes of implementing the recommended strategy or solutions. The engagement of contracted services for implementation can, at MD Anderson's discretion, be solicited via a second and separate Request for Proposal.
Standard Riders and Agreements
AA RFQ Major Project Commissioning Rev 1.pdf
Addendum 1 Agenda, Roster, HUB Tip Sheet.pdf
Addendum 2 RFI Questions and Answers.pdf
Addendum 3 Submittal Due Date Extended.pdf
Attachment A Draft Agreement.pdf
Attachment A1 Draft Agreement Exhibits.pdf
Attachment D Rider 101 Scope of Services.pdf
***Interested suppliers should also note that Subcontracting Opportunities are
probable in connection with this solicitation. Please review the HUB Subcontracting Tip Sheet
***RFx refers to RFP, RFQ, RFI, ITB, etc.